surmount-1 tirzepatide obesity nejm 2022 weight loss percent SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Retatrutide Phase 2 NEJM Trial:
Description
From there, follow the standard titration schedule with increases of 2.5 mg every four weeks as tolerated, up to a maximum of 15 mg weekly
Liquid calories from protein shakes, smoothies with added fats, and calorie-dense recovery meals become essential
Figure 2
Either way, you get a named, verifiable pharmacy rather than an anonymous partner
